Happy
''Huge'' step forward with devil cancer vaccine
The long battle to save the Tasmanian devil from its deadly facial cancer is set to pass a vital milestone, with the first release into the wild of immunised animals.
The 19 captive-bred devils have all responded to a trial vaccine developed by a team at the Menzies Institute for Medical Research in Hobart, who have been fighting the disease for nearly a decade.
